These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15025523)

  • 1. Dimers of D-myo-inositol 1,4,5-trisphosphate: design, synthesis, and interaction with Ins(1,4,5)P3 receptors.
    Riley AM; Laude AJ; Taylor CW; Potter BV
    Bioconjug Chem; 2004; 15(2):278-89. PubMed ID: 15025523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.
    Marchant JS; Beecroft MD; Riley AM; Jenkins DJ; Marwood RD; Taylor CW; Potter BV
    Biochemistry; 1997 Oct; 36(42):12780-90. PubMed ID: 9335535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the involvement of a small subregion of the endoplasmic reticulum in the inositol trisphosphate receptor-induced activation of Ca2+ inflow in rat hepatocytes.
    Gregory RB; Wilcox RA; Berven LA; van Straten NC; van der Marel GA; van Boom JH; Barritt GJ
    Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):401-8. PubMed ID: 10393099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Riley AM; Lindley CJ; Jenkins DJ; Westwick J; Potter BV
    Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interaction.
    Rosenberg HJ; Riley AM; Laude AJ; Taylor CW; Potter BV
    J Med Chem; 2003 Nov; 46(23):4860-71. PubMed ID: 14584937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-O-(2-Aminoethyl)-myo-inositol 1,4,5-trisphosphate as a novel ligand for conjugation: physicochemical properties and synthesis of a new Ins(1,4,5)P(3) affinity matrix.
    Riley AM; Dozol H; Spiess B; Potter BV
    Biochem Biophys Res Commun; 2004 May; 318(2):444-52. PubMed ID: 15120621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV
    J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition of adenophostin, a very potent Ca2+ inducer, at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Hotoda H; Murayama K; Miyamoto S; Iwata Y; Takahashi M; Kawase Y; Tanzawa K; Kaneko M
    Biochemistry; 1999 Jul; 38(29):9234-41. PubMed ID: 10413497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid activation and partial inactivation of inositol trisphosphate receptors by adenophostin A.
    Adkins CE; Wissing F; Potter BV; Taylor CW
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):929-33. PubMed ID: 11104705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor.
    Safrany ST; Sawyer DA; Nahorski SR; Potter BV
    Chirality; 1992; 4(7):415-22. PubMed ID: 1334423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-assisted total synthesis of the optical antipodes D-myo-inositol 3,4,5-trisphosphate and D-myo-inositol 1,5, 6-trisphosphate: aspects of their structure-activity relationship to biologically active inositol phosphates.
    Adelt S; Plettenburg O; Stricker R; Reiser G; Altenbach HJ; Vogel G
    J Med Chem; 1999 Apr; 42(7):1262-73. PubMed ID: 10197969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes.
    Gregory RB; Hughes R; Riley AM; Potter BV; Wilcox RA; Barritt GJ
    Biochem J; 2004 Jul; 381(Pt 2):519-26. PubMed ID: 15169542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. InsP(3)-induced Ca(2+) release in permeabilized invertebrate photoreceptors: a link between phototransduction and Ca(2+) stores.
    Ukhanov K; Mills SJ; Potter BV; Walz B
    Cell Calcium; 2001 May; 29(5):335-45. PubMed ID: 11292390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor.
    Moris MA; Caron AZ; Guillemette G; Rognan D; Schmitt M; Schlewer G
    J Med Chem; 2005 Feb; 48(4):1251-5. PubMed ID: 15715492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of inositol 1,4,5-trisphosphate (IP(3)) receptors with synthetic poly(ethylene glycol)-linked dimers of IP(3) suggest close spacing of the IP(3)-binding sites.
    Riley AM; Morris SA; Nerou EP; Correa V; Potter BV; Taylor CW
    J Biol Chem; 2002 Oct; 277(43):40290-5. PubMed ID: 12183463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
    J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.